Compounds > dehydrocostus lactone
Page last updated: 2024-08-25

dehydrocostus lactone and Cancer of Esophagus

dehydrocostus lactone has been researched along with Cancer of Esophagus in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Bahetjan, Y; Li, X; Peng, Y; Wang, S; Yang, X; Zhou, T1
Li, R; Lu, Z; Sheng, B; Xu, Q; Yang, G; Zhang, L1

Other Studies

2 other study(ies) available for dehydrocostus lactone and Cancer of Esophagus

ArticleYear
Dehydrocostus lactone inhibits the proliferation of esophageal cancer cells in vivo and in vitro through ROS-mediated apoptosis and autophagy.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2022, Volume: 170

    Topics: Animals; Apoptosis; Autophagy; Cell Line, Tumor; Cell Proliferation; Esophageal Neoplasms; Humans; Mice; Mice, Nude; Phosphatidylinositol 3-Kinases; Reactive Oxygen Species

2022
Dehydrocostus Lactone Induces Apoptosis and Cell Cycle Arrest through Regulation of JAK2/STAT3/PLK1 Signaling Pathway in Human Esophageal Squamous Cell Carcinoma Cells.
    Anti-cancer agents in medicinal chemistry, 2022, Volume: 22, Issue:9

    Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Interleukin-6; Janus Kinase 2; Lactones; RNA, Small Interfering; Sesquiterpenes; Signal Transduction; STAT3 Transcription Factor

2022